ID

13052

Beschreibung

Placebo controlled,double blind and randomized parallel group trial to verify effectivity and tolerability of moxaverine p.o. in patients with central nervous vertigo. Sponsor: URSAPHARM Industriestrasse 66129 Saarbrücken Phone 06805-9292-0 Fax 06805- 929288 Head of clinical trial: Univ.-Prof.Dr.med. Ralph Mösges Medical Faculty, University of Cologne Phone 0221-4783456 Fax 0221-4783465

Stichworte

  1. 13.01.16 13.01.16 -
Hochgeladen am

13. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Moxaverine 200mg p.o. in patients with central nervous vertigo Pharmacovigilance

Case Report Form Pharmacovigilance

Demographic Information
Beschreibung

Demographic Information

Patient number
Beschreibung

Patient number

Datentyp

integer

Alias
UMLS CUI [1]
C1830427
Study Site number
Beschreibung

Study Site

Datentyp

integer

Alias
UMLS CUI [1]
C2825164
Visit number
Beschreibung

Visit number

Datentyp

integer

Alias
UMLS CUI [1]
C1549755
Week as outlined in Follow-up schedule
Beschreibung

i.e week 1/2/...

Datentyp

integer

Alias
UMLS CUI [1]
C0439230
Patient Initials: first three characters of given and last name
Beschreibung

Patient Initials

Datentyp

text

Alias
UMLS CUI [1]
C2986440
Patient age
Beschreibung

Age

Datentyp

integer

Alias
UMLS CUI [1]
C0001779
Patient Gender
Beschreibung

Gender

Datentyp

text

Alias
UMLS CUI [1]
C0079399
Body height
Beschreibung

Height

Datentyp

integer

Maßeinheiten
  • cm
Alias
UMLS CUI [1]
C0005890
cm
Body weight
Beschreibung

Weight

Datentyp

float

Maßeinheiten
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Pharmacovigilance 1
Beschreibung

Pharmacovigilance 1

Please give the date the Adverse Event occurred
Beschreibung

Date

Datentyp

date

Alias
UMLS CUI [1]
C0011008
Please give a detailed discription of the AE
Beschreibung

i.e relevant clinical data,lab results, recent medical history and comorbidities

Datentyp

text

Alias
UMLS CUI [1]
C0678257
Plasma concentration of trial substance determinated?
Beschreibung

Medication plasma concentration

Datentyp

boolean

Alias
UMLS CUI [1]
C0013227
UMLS CUI [2]
C0683150
Laboratory Procedure Date
Beschreibung

Laboratory Procedure Date

Datentyp

date

Alias
UMLS CUI [1]
C0022885
UMLS CUI [2]
C0011008
Please specify plasma concentration of trial substance
Beschreibung

Plasma concentration

Datentyp

float

Alias
UMLS CUI [1]
C0022885
UMLS CUI [2]
C0683150
Please specify any medication used starting with trial substance
Beschreibung

Medication

Datentyp

text

Alias
UMLS CUI [1]
C0013227
Please specify dose of applied substance, frequency and route of administration
Beschreibung

Medication dose,frequency and route of administration

Datentyp

text

Alias
UMLS CUI [1]
C3174092
UMLS CUI [2]
C0439603
UMLS CUI [3]
C0013153
Date the medication was started
Beschreibung

Start Date

Datentyp

date

Alias
UMLS CUI [1]
C0808070
Date medication was stopped
Beschreibung

End date

Datentyp

date

Alias
UMLS CUI [1]
C0806020
Please specify any Indication for medications administered using ICD Codes
Beschreibung

Indication

Datentyp

text

Alias
UMLS CUI [1]
C3146298
Signature Date
Beschreibung

Date

Datentyp

date

Alias
UMLS CUI [1]
C0011008
Signature
Beschreibung

Signature

Datentyp

text

Alias
UMLS CUI [1]
C1519316
Pharmacovigilance 2
Beschreibung

Pharmacovigilance 2

Date of first occurrence of the AE
Beschreibung

Date

Datentyp

date

Alias
UMLS CUI [1]
C0011008
Has the trial substance been discontinued?
Beschreibung

Treatment of AE

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
Event resulted in a hospitalization
Beschreibung

Hospitalization

Datentyp

boolean

Alias
UMLS CUI [1]
C0019993
Date of hospitalization due to the AE
Beschreibung

Date

Datentyp

date

Alias
UMLS CUI [1]
C0011008
Has the hospitalization of an inpatient been prolonged due to the AE?
Beschreibung

Hospitalization

Datentyp

boolean

Alias
UMLS CUI [1]
C0019993
Please give a detailed description of actions taken
Beschreibung

i.e: timing, determining factors,discontinuation of medications,clinical status of patient at this point,...

Datentyp

text

Alias
UMLS CUI [1]
C0678257
Please give your opinion on the correlation of the reported AE with the trial
Beschreibung

Opinion

Datentyp

text

Alias
UMLS CUI [1]
C0871010
Please list all enclosed documents
Beschreibung

i.e: hospital report,lab test report, other tests contributing to a diagnose

Datentyp

text

Alias
UMLS CUI [1]
C1301746
Please give name and qualification of completing health care professional
Beschreibung

Name and qualification

Datentyp

text

Alias
UMLS CUI [1]
C0027365
UMLS CUI [2]
C1547648
Signature Date
Beschreibung

Date

Datentyp

date

Alias
UMLS CUI [1]
C0011008
Signature
Beschreibung

Signature

Datentyp

text

Alias
UMLS CUI [1]
C1519316

Ähnliche Modelle

Case Report Form Pharmacovigilance

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Demographic Information
Patient number
Item
Patient number
integer
C1830427 (UMLS CUI [1])
Study Site
Item
Study Site number
integer
C2825164 (UMLS CUI [1])
Visit number
Item
Visit number
integer
C1549755 (UMLS CUI [1])
Week
Item
Week as outlined in Follow-up schedule
integer
C0439230 (UMLS CUI [1])
Patient Initials
Item
Patient Initials: first three characters of given and last name
text
C2986440 (UMLS CUI [1])
Age
Item
Patient age
integer
C0001779 (UMLS CUI [1])
Item
Patient Gender
text
C0079399 (UMLS CUI [1])
Code List
Patient Gender
CL Item
Male (m)
CL Item
Female (f)
Height
Item
Body height
integer
C0005890 (UMLS CUI [1])
Weight
Item
Body weight
float
C0005910 (UMLS CUI [1])
Item Group
Pharmacovigilance 1
Date
Item
Please give the date the Adverse Event occurred
date
C0011008 (UMLS CUI [1])
Description
Item
Please give a detailed discription of the AE
text
C0678257 (UMLS CUI [1])
Medication plasma concentration
Item
Plasma concentration of trial substance determinated?
boolean
C0013227 (UMLS CUI [1])
C0683150 (UMLS CUI [2])
Laboratory Procedure Date
Item
Laboratory Procedure Date
date
C0022885 (UMLS CUI [1])
C0011008 (UMLS CUI [2])
Plasma concentration
Item
Please specify plasma concentration of trial substance
float
C0022885 (UMLS CUI [1])
C0683150 (UMLS CUI [2])
Medication
Item
Please specify any medication used starting with trial substance
text
C0013227 (UMLS CUI [1])
Medication dose,frequency and route of administration
Item
Please specify dose of applied substance, frequency and route of administration
text
C3174092 (UMLS CUI [1])
C0439603 (UMLS CUI [2])
C0013153 (UMLS CUI [3])
Start Date
Item
Date the medication was started
date
C0808070 (UMLS CUI [1])
End date
Item
Date medication was stopped
date
C0806020 (UMLS CUI [1])
Indication
Item
Please specify any Indication for medications administered using ICD Codes
text
C3146298 (UMLS CUI [1])
Date
Item
Signature Date
date
C0011008 (UMLS CUI [1])
Signature
Item
Signature
text
C1519316 (UMLS CUI [1])
Item Group
Pharmacovigilance 2
Date
Item
Date of first occurrence of the AE
date
C0011008 (UMLS CUI [1])
Treatment of AE
Item
Has the trial substance been discontinued?
boolean
C0087111 (UMLS CUI [1])
Hospitalization
Item
Event resulted in a hospitalization
boolean
C0019993 (UMLS CUI [1])
Date
Item
Date of hospitalization due to the AE
date
C0011008 (UMLS CUI [1])
Hospitalization
Item
Has the hospitalization of an inpatient been prolonged due to the AE?
boolean
C0019993 (UMLS CUI [1])
Description
Item
Please give a detailed description of actions taken
text
C0678257 (UMLS CUI [1])
Item
Please give your opinion on the correlation of the reported AE with the trial
text
C0871010 (UMLS CUI [1])
Code List
Please give your opinion on the correlation of the reported AE with the trial
CL Item
no obvious correlation with the study (1)
CL Item
questionable influence of trial substance (2)
CL Item
possible influence of trial substance (3)
CL Item
likely influence of trial substance (4)
CL Item
cannot be determined at this point (5)
Documents
Item
Please list all enclosed documents
text
C1301746 (UMLS CUI [1])
Name and qualification
Item
Please give name and qualification of completing health care professional
text
C0027365 (UMLS CUI [1])
C1547648 (UMLS CUI [2])
Date
Item
Signature Date
date
C0011008 (UMLS CUI [1])
Signature
Item
Signature
text
C1519316 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video